Flavoxate Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 200 mg
Reference Brands: Urispas® (EU & US)
Category:
Nephrology
Flavoxate Tablets are used to treat urinary tract conditions such as overactive bladder, bladder spasms, and urinary incontinence. As an anticholinergic, it helps relax the bladder muscles, reducing urinary urgency and frequency.
Flavoxate is available in Tablet
and strengths such as 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Flavoxate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Flavoxate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Flavoxate Tablets are widely used in urology to treat urinary tract conditions such as overactive bladder, bladder spasms, and urinary incontinence. As an anticholinergic medication, Flavoxate helps to relax bladder muscles, reducing urinary urgency and frequency. Available in tablet form, it is commonly prescribed to improve urinary symptoms in patients with neurogenic bladder or other conditions affecting bladder function. For B2B distribution in the US and EU, Flavoxate serves as an important treatment option for healthcare providers addressing urinary disorders. Its broad use in urology makes it a key product for pharmaceutical companies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing